Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea
· Delayed Price · Currency is KRW 80,000
-2,100 (-2.56%)
At close: Dec 5, 2025
Kolon TissueGene Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -87,457 | -33,799 | -17,224 | -11,136 | -47,370 | -41,788 | Upgrade
|
| Depreciation & Amortization | 739.99 | 808.55 | 1,412 | 1,665 | 1,551 | 1,642 | Upgrade
|
| Loss (Gain) From Sale of Assets | -58.01 | -1.02 | 2.17 | - | 14.87 | -0.5 | Upgrade
|
| Stock-Based Compensation | 104 | 79.18 | 67.24 | - | - | 1.33 | Upgrade
|
| Provision & Write-off of Bad Debts | 30.01 | 3.14 | -29.57 | 241.9 | -107.67 | -89.82 | Upgrade
|
| Other Operating Activities | 67,627 | 13,103 | -664.36 | -5,653 | 924 | 1,306 | Upgrade
|
| Change in Accounts Receivable | -22.81 | -57.29 | -120.38 | 58.7 | 343.57 | 336.82 | Upgrade
|
| Change in Inventory | 26.69 | -34.56 | -47.43 | 89.39 | 124.41 | 61.74 | Upgrade
|
| Change in Accounts Payable | -119.62 | 71.87 | 150.82 | 12.34 | -151.61 | -218.86 | Upgrade
|
| Change in Income Taxes | - | - | - | - | -218.54 | -134.56 | Upgrade
|
| Change in Other Net Operating Assets | -4,486 | -626.28 | -7,655 | -12,054 | 4,870 | 758.25 | Upgrade
|
| Operating Cash Flow | -23,616 | -20,452 | -24,109 | -26,776 | -40,020 | -38,125 | Upgrade
|
| Capital Expenditures | -1,202 | -129.26 | -260.58 | -68.52 | -548.04 | -826.74 | Upgrade
|
| Sale of Property, Plant & Equipment | 59.78 | 1.99 | 1.36 | - | 0.25 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -107,271 | -77,123 | -45,937 | -24,275 | -5,589 | -12.91 | Upgrade
|
| Investment in Securities | -17,628 | - | 17,196 | -15,557 | 39,576 | 19,676 | Upgrade
|
| Other Investing Activities | -18.37 | 5.24 | -39.24 | -156.38 | -89.34 | -128 | Upgrade
|
| Investing Cash Flow | -126,059 | -77,245 | -29,039 | -40,057 | 33,419 | 18,708 | Upgrade
|
| Long-Term Debt Issued | - | 23,822 | - | - | - | - | Upgrade
|
| Total Debt Issued | 179,013 | 23,822 | - | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -5,722 | - | Upgrade
|
| Long-Term Debt Repaid | - | -1,291 | -1,165 | -1,103 | -3,923 | -6,884 | Upgrade
|
| Total Debt Repaid | -1,367 | -1,291 | -1,165 | -1,103 | -9,645 | -6,884 | Upgrade
|
| Net Debt Issued (Repaid) | 177,646 | 22,532 | -1,165 | -1,103 | -9,645 | -6,884 | Upgrade
|
| Issuance of Common Stock | 43,549 | 46,937 | 39,268 | 37,366 | 34,227 | - | Upgrade
|
| Other Financing Activities | - | -0 | - | 30,646 | - | - | Upgrade
|
| Financing Cash Flow | 221,195 | 69,468 | 38,102 | 66,909 | 24,582 | -6,884 | Upgrade
|
| Foreign Exchange Rate Adjustments | -18.02 | -45.52 | 6.64 | -4.43 | 5.09 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | - | 0 | Upgrade
|
| Net Cash Flow | 71,502 | -28,274 | -15,039 | 72.76 | 17,986 | -26,302 | Upgrade
|
| Free Cash Flow | -24,817 | -20,581 | -24,370 | -26,844 | -40,568 | -38,952 | Upgrade
|
| Free Cash Flow Margin | -488.83% | -405.66% | -657.56% | -283.88% | -1013.40% | -1095.44% | Upgrade
|
| Free Cash Flow Per Share | -304.98 | -267.44 | -339.84 | -404.97 | -662.52 | -637.95 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 119.8 | 374.11 | Upgrade
|
| Cash Income Tax Paid | - | -95.76 | 251.76 | 1,318 | - | - | Upgrade
|
| Levered Free Cash Flow | -9,221 | -46,515 | -54,983 | -38,159 | -25,649 | -25,937 | Upgrade
|
| Unlevered Free Cash Flow | -9,221 | -46,459 | -54,804 | -37,927 | -25,358 | -25,415 | Upgrade
|
| Change in Working Capital | -4,601 | -646.25 | -7,672 | -11,894 | 4,968 | 803.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.